tiprankstipranks
Trending News
More News >
Humacyte (HUMA)
NASDAQ:HUMA
US Market

Humacyte (HUMA) Similar Stocks

Compare
1,176 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Humacyte
$1.49
$237.33M
-51.31%
5 Buy
0 Hold
0 Sell
Strong Buy
Vanda
$4.36
$254.26M
7.39%
2 Buy
0 Hold
0 Sell
Moderate Buy
Palvella Therapeutics
$24.44
$269.30M
79.71%
9 Buy
0 Hold
0 Sell
Strong Buy
Atea Pharmaceuticals
$2.71
$251.44M
-21.81%
1 Buy
1 Hold
0 Sell
Moderate Buy
Compass Therapeutics
$1.72
$234.39M
8.86%
6 Buy
0 Hold
0 Sell
Strong Buy
Candel Therapeutics
$5.17
$234.76M
-11.17%
4 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HUMA
Humacyte
1.49
-1.57
-51.31%
VNDA
Vanda
4.36
0.31
7.65%
PVLA
Palvella Therapeutics
24.44
11.32
86.28%
AVIR
Atea Pharmaceuticals
2.94
-0.80
-21.39%
CMPX
Compass Therapeutics
1.72
0.15
9.55%
CADL
Candel Therapeutics
5.17
-0.72
-12.22%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis